TRNT1 Gene: tRNA Nucleotidyl Transferase 1 - Function, Disease Associations, and Clinical Significance

Comprehensive guide to TRNT1 (CCA-adding enzyme), its role in tRNA maturation, associated disorders (SIFD, retinitis pigmentosa, sideroblastic anemia), and mutation spectrum.

Gene Information Card

Symbol TRNT1
Full Name tRNA nucleotidyl transferase 1
Gene Type protein coding
Chromosomal Location 3p26.2
NCBI Gene ID 51095 ncbi.nlm.nih.gov/gene/51095
Ensembl ID ENSG00000114686
UniProt ID Q96Q11
OMIM ID 612907
HGNC ID 16941
Aliases CCA1, CCA-adding enzyme, mt CCA-adding enzyme, TRNT1, FLJ12770

Description

The TRNT1 gene encodes tRNA nucleotidyl transferase 1, an essential enzyme that adds the conserved CCA sequence to the 3' end of transfer RNAs (tRNAs). This modification is critical for tRNA aminoacylation and ribosomal protein synthesis. TRNT1 functions in both the cytoplasm and mitochondria, and its deficiency leads to impaired mitochondrial translation and multiple systemic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Sideroblastic anemia with B-cell immunodeficiency, periodic fever, and developmental delay (SIFD) Loss-of-function mutations in TRNT1 impair CCA addition, leading to defective tRNA maturation and mitochondrial dysfunction, causing multi-system disease. ClinVar, OMIM (612907), PMID: 24651126
Retinitis pigmentosa (RP) TRNT1 mutations cause progressive retinal degeneration due to mitochondrial dysfunction in photoreceptor cells. ClinVar, PMID: 28771248
Combined oxidative phosphorylation deficiency (mitochondrial disease) Impaired mitochondrial tRNA processing leads to respiratory chain defects and energy deficiency. OMIM, PMID: 24651126
Congenital sideroblastic anemia (CSA) Mitochondrial iron metabolism disruption due to defective translation of mitochondrial proteins. ClinVar, PMID: 24651126
Immunodeficiency (B-cell deficiency) TRNT1 mutations affect B-cell development and function, leading to recurrent infections. OMIM, PMID: 24651126

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 10.2 Medium
Heart 8.7 Medium
Brain 6.3 Low
Skeletal Muscle 5.1 Low
Testis 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.3 High expression
K562 12.1 Medium
A549 10.8 Medium
HepG2 9.5 Medium
MCF7 7.2 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.124A>G (p.Lys42Glu) Missense Rare (found in SIFD patients) Impairs catalytic activity, reduces CCA addition
c.446T>C (p.Leu149Pro) Missense Rare (found in retinitis pigmentosa) Disrupts protein folding and enzyme function
c.868G>A (p.Gly290Arg) Missense Rare (found in SIFD) Affects substrate binding, reduced activity
c.1052C>T (p.Pro351Leu) Missense Rare (found in SIFD) Impairs mitochondrial localization
c.1225A>G (p.Thr409Ala) Missense Rare (found in SIFD) Reduced enzyme stability
c.1357C>T (p.Arg453Trp) Missense Rare (found in SIFD) Loss of function, severe phenotype
Mutation functional classification

Loss of Function (LOF)

Most TRNT1 mutations are loss-of-function, reducing or abolishing CCA-adding activity, leading to impaired tRNA maturation and mitochondrial dysfunction.

Gain of Function (GOF)

No gain-of-function mutations reported for TRNT1.

Dominant Negative (DN)

No dominant-negative effects reported; TRNT1 mutations are typically autosomal recessive.

Gene Ontology (GO)

• nucleotidyltransferase activity • tRNA binding
• ATP binding • magnesium ion binding
• tRNA nucleotidyltransferase activity • mitochondrion
• cytoplasm • tRNA processing
• tRNA 3'-terminal CCA addition • mitochondrial tRNA processing

Pathways

tRNA processing and modification
Mitochondrial translation
Aminoacyl-tRNA biosynthesis

Protein Summary

TRNT1 is a 434-amino acid protein that belongs to the nucleotidyltransferase family. It catalyzes the addition of CCA nucleotides to the 3' end of tRNAs, a critical step for tRNA function. The enzyme is localized in both the cytoplasm and mitochondria, with a mitochondrial targeting sequence. It functions as a homodimer and requires divalent metal ions (e.g., Mg2+) for activity. Defects in TRNT1 lead to impaired protein synthesis, particularly in mitochondria, causing a spectrum of clinical phenotypes.

Related Products

Product name Cat.No. Species Gene ID
TRNT1 Knockout HEK293 Cell Line EDJ-KQ51280 Human 51095 Details Get a Quote
TRNT1 Knockout HeLa Cell Line EDJ-KQ56228 Human 51095 Details Get a Quote
TRNT1 Knockout A-549 Cell Line EDJ-KQ64718 Human 51095 Details Get a Quote
TRNT1 Knockout HCT 116 Cell Line EDJ-KQ73162 Human 51095 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: